Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
BeOne Medicines NasdaqGS:ONC |
31,41 B | 71,53% | 5/6 | 19,62% | 23,50% | 43,02% | DOWN |
|
CRISPR Therapeutics NasdaqGM:CRSP |
4,52 B | 30,82% | 2/6 | 1267,38% | 52,72% | 69,89% | DOWN |
|
Oculis Holding NasdaqGM:OCS |
1,48 B | -33,93% | 0/0 | 399,17% | -14,34% | 94,80% | UP |
|
MoonLake Immunotherapeutics NasdaqCM:MLTX |
1,29 B | 0,00% | 0/4 | 0,00% | 0,00% | 53,29% | DOWN |
|
Kuros Biosciences SWX:KURN |
0,90 B | 0,00% | 6/6 | 19,34% | 98,93% | 54,99% | DOWN |
|
Idorsia Ltd SWX:IDIA |
0,80 B | 26,66% | 4/6 | 9,73% | 87,28% | 42,41% | UP |
|
Basilea Pharmaceutica SWX:BSLN |
0,64 B | 66,74% | 5/6 | 15,54% | 5,86% | 68,28% | UP |
|
ADC Therapeutics NYSE:ADCT |
0,50 B | -7,66% | 2/3 | -15,68% | -318,02% | 101,51% | UP |
|
AC Immune NasdaqGM:ACIU |
0,29 B | -29,31% | 1/6 | 691,84% | -126,62% | 189,80% | DOWN |
|
VectivBio Holding NasdaqGM:VECT |
0,17 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | UP |
|
Molecular Partners SWX:MOLN |
0,13 B | -32,25% | 2/6 | 100,00% | -405,45% | 168,66% | UP |
|
Polyphor SWX:POLN |
0,02 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Relief Therapeutics Holding SWX:MMTX |
0,01 B | 42,95% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
ObsEva OTCPK:OBSE.F |
0,00 B | 225,03% | 1/3 | 0,00% | 0,00% | 0,00% | DOWN |
